Healthcare provider profile · identity verified

Rhett R Smith, M.D.

Family Practice · BEAVER, UT · NPI 1568800209

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	375	81
Omeprazole	Omeprazole	213	59
Alprazolam	Alprazolam	206	35
Pantoprazole Sodium	Pantoprazole Sodium	184	58
Celecoxib	Celecoxib	175	46
Atorvastatin Calcium	Atorvastatin Calcium	173	48
Gabapentin	Gabapentin	156	38
Rosuvastatin Calcium	Rosuvastatin Calcium	144	37
Eliquis	Apixaban	140	16
Losartan Potassium	Losartan Potassium	140	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	124	33
Potassium Chloride	Potassium Chloride	122	33
Tamsulosin Hcl	Tamsulosin Hcl	119	33
Amlodipine Besylate	Amlodipine Besylate	110	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	30
Furosemide	Furosemide	104	30
Escitalopram Oxalate	Escitalopram Oxalate	101	24
Tramadol Hcl	Tramadol Hcl	97	13
Trazodone Hcl	Trazodone Hcl	97	24
Fluoxetine Hcl	Fluoxetine Hcl	96	21
Pregabalin	Pregabalin	92	15
Spironolactone	Spironolactone	88	33
Estradiol	Estradiol	85	19
Lisinopril	Lisinopril	84	23
Simvastatin	Simvastatin	82	20
Zolpidem Tartrate	Zolpidem Tartrate	82	13
Metformin Hcl	Metformin Hcl	81	24
Metformin Hcl Er	Metformin Hcl	77	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	75	20
Famotidine	Famotidine	74	12
Carvedilol	Carvedilol	71	13
Tizanidine Hcl	Tizanidine Hcl	67	14
Atenolol	Atenolol	65	19
Oxycodone Hcl	Oxycodone Hcl	64	12
Metoprolol Tartrate	Metoprolol Tartrate	63	14
Allopurinol	Allopurinol	62	15
Hydrochlorothiazide	Hydrochlorothiazide	61	15
Sertraline Hcl	Sertraline Hcl	61	16
Prednisone	Prednisone	56	44
Ropinirole Hcl	Ropinirole Hcl	55	suppressed
Metoprolol Succinate	Metoprolol Succinate	53	11
Lorazepam	Lorazepam	47	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Torsemide	Torsemide	47	16
Pravastatin Sodium	Pravastatin Sodium	46	14
Montelukast Sodium	Montelukast Sodium	45	14
Oxybutynin Chloride Er	Oxybutynin Chloride	45	11
Amitriptyline Hcl	Amitriptyline Hcl	44	suppressed
Ondansetron Odt	Ondansetron	44	21
Fluticasone Propionate	Fluticasone Propionate	43	24
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Warfarin Sodium	Warfarin Sodium	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	39	11
Finasteride	Finasteride	39	14
Pioglitazone Hcl	Pioglitazone Hcl	39	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	14
Glimepiride	Glimepiride	38	14
Albuterol Sulfate Hfa	Albuterol Sulfate	37	12
Synthroid	Levothyroxine Sodium	37	11
Cefdinir	Cefdinir	36	33
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Dutasteride	Dutasteride	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Fluconazole	Fluconazole	31	22
Nystatin	Nystatin	31	16
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	30	14
Xarelto	Rivaroxaban	30	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	29	suppressed
Ibandronate Sodium	Ibandronate Sodium	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Azithromycin	Azithromycin	27	19
Fentanyl	Fentanyl	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Vraylar	Cariprazine Hcl	25	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Januvia	Sitagliptin Phosphate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Amoxicillin	Amoxicillin	22	20
Glipizide	Glipizide	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Temazepam	Temazepam	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Clonazepam	Clonazepam	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Cephalexin	Cephalexin	20	14
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	20	suppressed
Mupirocin	Mupirocin	20	16
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Diazepam	Diazepam	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Easy Comfort Pen Needles	Pen Needle, Diabetic	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Topiramate	Topiramate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Triazolam	Triazolam	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error